Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
40.82
-0.71 (-1.71%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Azenta Revenue
Azenta had revenue of $172.81M in the quarter ending June 30, 2024, with 4.13% growth. This brings the company's revenue in the last twelve months to $658.62M, up 4.50% year-over-year. In the fiscal year ending September 30, 2023, Azenta had annual revenue of $665.07M with 19.73% growth.
Revenue (ttm)
$658.62M
Revenue Growth
+4.50%
P/S Ratio
3.54
Revenue / Employee
$188,176
Employees
3,500
Market Cap
2.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 665.07M | 109.57M | 19.73% |
Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
Sep 30, 2019 | 334.18M | -297.38M | -47.09% |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Sep 30, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Alignment Healthcare | 2.23B |
Privia Health Group | 1.70B |
Tandem Diabetes Care | 796.00M |
Warby Parker | 719.93M |
UFP Technologies | 417.47M |
SpringWorks Therapeutics | 86.19M |
Intellia Therapeutics | 45.97M |
Keros Therapeutics | 271.00K |
AZTA News
- 7 weeks ago - AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO - PRNewsWire
- 2 months ago - GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event - PRNewsWire
- 2 months ago - Azenta, Inc. (AZTA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 - PRNewsWire
- 2 months ago - Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference - PRNewsWire
- 3 months ago - Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast - PRNewsWire
- 3 months ago - FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study - PRNewsWire
- 5 months ago - Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research - PRNewsWire